Consensus Shanghai Henlius Biotech, Inc.

Equities

Delayed Hong Kong S.E. Other stock markets 23:58:13 2024-04-28 EDT			5-day change	1st Jan Change
16.6 ^HKD	+0.61%		+8.78%	+19.42%

04-26	Shanghai Henlius Biotech's Cancer Drug Gets the Nod from US FDA	MT
04-24	Shanghai Henlius Biotech Doses 1st Patient in Fibrosis Drug Clinical Study in China	MT

1eb6013.htM0cIc1mkG4oF-itVNwPnblCmD-pWHug82VNluOtE8.3ql5QrQH1Dn6xzyRwjo6WRS_XReJxgyq-oHaAwHg-RXitH0I_3fiA_PhEg~adf02ca8839249cfd404954f2351a4f1

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

15.27 CNY

Average target price

16.39 CNY

Spread / Average Target

+7.30%

High Price Target

23.05 CNY

Spread / Highest target

+50.91%

Low Price Target

8.352 CNY

Spread / Lowest Target

-45.32%

Trading Rating

Investor Rating

ESG Refinitiv